JP2008534522A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008534522A5 JP2008534522A5 JP2008503332A JP2008503332A JP2008534522A5 JP 2008534522 A5 JP2008534522 A5 JP 2008534522A5 JP 2008503332 A JP2008503332 A JP 2008503332A JP 2008503332 A JP2008503332 A JP 2008503332A JP 2008534522 A5 JP2008534522 A5 JP 2008534522A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- manufacturing
- disorders
- pharmaceutical
- bed drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 206010010904 Convulsion Diseases 0.000 claims 4
- 208000015114 central nervous system disease Diseases 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 239000007921 spray Substances 0.000 claims 3
- 238000005550 wet granulation Methods 0.000 claims 3
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 2
- 206010020852 Hypertonia Diseases 0.000 claims 2
- 206010021143 Hypoxia Diseases 0.000 claims 2
- 206010026749 Mania Diseases 0.000 claims 2
- 208000026139 Memory disease Diseases 0.000 claims 2
- 208000019695 Migraine disease Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 208000028683 bipolar I disease Diseases 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 206010015037 epilepsy Diseases 0.000 claims 2
- 239000003979 granulating agent Substances 0.000 claims 2
- 208000013403 hyperactivity Diseases 0.000 claims 2
- 230000001146 hypoxic effect Effects 0.000 claims 2
- 230000000302 ischemic effect Effects 0.000 claims 2
- HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical group CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 claims 2
- 229960004002 levetiracetam Drugs 0.000 claims 2
- 206010027599 migraine Diseases 0.000 claims 2
- 201000003152 motion sickness Diseases 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2505463 | 2005-03-30 | ||
| PCT/CA2006/000470 WO2006102750A1 (en) | 2005-03-30 | 2006-03-30 | Combined-step process for pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008534522A JP2008534522A (ja) | 2008-08-28 |
| JP2008534522A5 true JP2008534522A5 (https=) | 2009-04-02 |
Family
ID=37052908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503332A Pending JP2008534522A (ja) | 2005-03-30 | 2006-03-30 | 医薬組成物のための複合ステップ製造方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8216611B2 (https=) |
| EP (1) | EP1871363A4 (https=) |
| JP (1) | JP2008534522A (https=) |
| AU (1) | AU2006228947A1 (https=) |
| WO (1) | WO2006102750A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080014271A1 (en) * | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| FR2912056B1 (fr) * | 2007-02-05 | 2009-12-18 | Rd Pharmagal | Composition a liberation prolongee de levetiracetam et procede de preparation |
| CA2696977C (en) | 2007-10-16 | 2012-12-04 | Pharmathen S.A. | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
| JP2010024156A (ja) * | 2008-07-16 | 2010-02-04 | Ucb Pharma Sa | レベチラセタムを含む医薬組成物 |
| DK3260118T3 (da) | 2008-10-16 | 2021-04-19 | Univ Johns Hopkins | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| EP2179725A1 (en) * | 2008-10-23 | 2010-04-28 | LEK Pharmaceuticals D.D. | Pharmaceutical composition comprising levetiracetam |
| EA202092673A3 (ru) * | 2010-02-09 | 2021-05-31 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| MX365513B (es) | 2013-03-15 | 2019-06-06 | Aprecia Pharmaceuticals LLC | Forma de dosificacion de dispersion rapida que contiene levetiracetam. |
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| JP6422464B2 (ja) * | 2016-05-19 | 2018-11-14 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
| JP7264711B2 (ja) * | 2019-04-26 | 2023-04-25 | 東和薬品株式会社 | レベチラセタム含有医薬組成物の製造方法 |
| CN115350178B (zh) * | 2022-08-24 | 2024-04-26 | 浙江京新药业股份有限公司 | 一种包含左乙拉西坦的药物组合物 |
| CN119679738B (zh) * | 2025-02-27 | 2025-06-20 | 福安药业集团宁波天衡制药有限公司 | 一种巴氯芬片及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| US5204115A (en) * | 1990-12-12 | 1993-04-20 | Suomen Xyrofin Oy | Directly compressible xylitol and method |
| DE19613395A1 (de) * | 1996-04-03 | 1997-10-09 | Basf Ag | Granulate hygroskopischer, wasserlöslicher Produkte |
| JPH11319534A (ja) * | 1998-03-18 | 1999-11-24 | Hosokawa Micron Corp | 造粒装置 |
| JP2000281561A (ja) * | 1999-03-26 | 2000-10-10 | Ajinomoto Co Inc | 新規溶媒法固体分散体製剤 |
| SI1214076T1 (en) * | 1999-08-31 | 2004-06-30 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| US6264983B1 (en) * | 1999-09-16 | 2001-07-24 | Rhodia, Inc. | Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| CA2475026A1 (en) | 1999-12-01 | 2001-06-07 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| EP1118321A1 (fr) * | 2000-01-14 | 2001-07-25 | Ucb, S.A. | Compositions pharmaceutiques solides pour la libération contrôlée de substances actives |
| JP4039782B2 (ja) * | 2000-02-15 | 2008-01-30 | 小川香料株式会社 | 粉末酸味料組成物及びその製造方法 |
| US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| DE10224170A1 (de) * | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
| AU2003301654A1 (en) * | 2002-10-22 | 2004-05-13 | Dainippon Pharmaceutical Co., Ltd. | Stabilized composition |
| CA2515090A1 (en) | 2003-02-03 | 2004-08-19 | Teva Pharmaceutical Industries Ltd | Process for producing levetiracetam |
| WO2004100992A2 (en) | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines |
| EA014249B1 (ru) * | 2005-01-27 | 2010-10-29 | Алембик Лимитед | Формуляция леветирацетама длительного высвобождения |
| US8431156B2 (en) * | 2005-02-22 | 2013-04-30 | Sun Pharma Advanced Research Company Ltd. | Pharmaceutical composition |
-
2006
- 2006-03-30 JP JP2008503332A patent/JP2008534522A/ja active Pending
- 2006-03-30 EP EP06741364A patent/EP1871363A4/en not_active Ceased
- 2006-03-30 WO PCT/CA2006/000470 patent/WO2006102750A1/en not_active Ceased
- 2006-03-30 AU AU2006228947A patent/AU2006228947A1/en not_active Abandoned
- 2006-03-30 US US11/910,434 patent/US8216611B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008534522A5 (https=) | ||
| AU2024201739B2 (en) | Dosage forms of controlled release at specific gastrointestinal sites | |
| ES2548886T3 (es) | Comprimidos bicapa que comprenden elvitegravir, cobicistat, emtricitabina y tenofovir | |
| HRP20100674T1 (hr) | Farmaceutski pripravak koji sadrzi omega-karboksiaril supstituirani difenil ureu za lijecenje raka | |
| US20120093738A1 (en) | Taste-masked oral formulations of influenza antivirals | |
| CN101283991B (zh) | 口腔崩解剂及其制造方法 | |
| AU2011316103B2 (en) | Phosphate binder formulation for simple ingestion | |
| JP2022153638A5 (https=) | ||
| WO1999047124A1 (en) | Tablets quickly disintegrating in the oral cavity and process for producing the same | |
| JP7336388B2 (ja) | 錠剤及びその製造方法 | |
| WO2002069933A1 (fr) | Comprimés à délitement rapide dans la bouche | |
| TW200635618A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| JP2006527184A5 (https=) | ||
| JP2009537478A5 (https=) | ||
| JPWO2010038688A1 (ja) | アトルバスタチン経口投与用粒子状医薬組成物 | |
| WO2012173581A4 (en) | Thiocolchicoside, etodolac and famotidine combinations | |
| JP2018526345A5 (https=) | ||
| JP5062872B2 (ja) | 不快な味を低減した口腔内崩壊錠剤 | |
| WO2011121823A1 (ja) | 経口投与用粒子状医薬組成物 | |
| JP2009508916A5 (https=) | ||
| JP6164346B2 (ja) | 口腔内崩壊錠の製造方法 | |
| JP2008500287A5 (https=) | ||
| JP2013237651A (ja) | ピタバスタチンの口腔内崩壊錠 | |
| JP2010530890A5 (https=) | ||
| JP2009235066A (ja) | 被覆微粒子含有口腔内崩壊錠 |